Mango butter—also known as mango oil and mango kernel fat—is a type of oil that is extracted from the kernels of mango seeds. But what is the big deal about mango butter? Well, it is packed with a lot of nutrients that are extremely beneficial for your skin.

How Does Mango Butter Help Skin?

It is generally non-comedogenic. Mango butter does not have compounds that are known to irritate skin, even if yours is sensitive. One exception to this is that if you have acne, you may avoid using mango butter on your face.

Moreover, mango butter also protects from harmful Ultraviolet (UV) Rays. Mango contains salicylic acid and antioxidants, which are known to protect from sun damage.

Most notably, Vitamins C and E are in rich supply in mangoes. A 2012 study suggests that, when combined, these two ingredients may provide some protection for your skin against environmental damage.

There is no heavy scent in mango butter. While you might expect a fruity zing, most people report a mild scent.

It's antibacterial and antimicrobial, which helps clear skin. In a 2020 study, wool treated with mango seed oil was less susceptible to the presence of various types of bacteria.

It may make your hair shiny. The same properties that promote soft skin may also boost your hair's natural shine and reduce scalp dryness and flakiness.

What Is In Mango Butter That Makes It So Special?

Mangoes are loaded with nutritious substances, which is partly why they are a dietary staple around the world. They are packed with fibre, vitamins (C, B6, A, E, and more), and minerals. They are also a good source of folate, potassium, calcium, and beta-carotene.

Many of the vitamins found in mango hold skin-improving powers, so it makes sense to blend it into butter.

ALSO READ: This One “Fattening” Vegetable Could Actually Be A Part Of You Weight Loss Diet

Thanks to its fatty acid profile (it is chock-full of oleic, stearic, and linoleic acids), mango butter is used as a substitute in beauty products for cocoa butter, a long-time skin-softening favourite.

As a topical cream, it can pass along benefits like softer skin, and may offer UV protection. The same 2020 study mentioned above suggests that wool treated with mango seed oil showed a decreased amount of UV damage—so it may do the same for the skin.

Mango butter also performed spectacularly in a small 2008 study on treatments for cracked heels. A mango butter-based solution worked better than a commercially produced lotion regarding the reduction of scars and cracks in the skin and increased shelf life. It also showed similar or better results in its ability to moisturize.

ALSO READ: Is Yerba Mate Nature's Answer To Ozempic? Risks And Benefits

Even after decades of health education campaigns and medical breakthroughs, there is still one myth that dangerously persistent—the heart disease is a "man's disease." This misconception has contributed to a fatal blind spot in diagnosing, treating, and managing women across the globe. The reality is even more sinister: cardiovascular disease (CVD) is the world's biggest killer of women, killing more people annually than all cancers together.

What's even more troubling is that the problem continues to exist in the face of decades of data, research, and advocacy by groups such as the American Heart Association (AHA), who continue to raise the alarm. Women are being misdiagnosed, underdiagnosed, and undertreated—particularly young women and women of color—resulting in avoidable deaths and long-term health repercussions.

Young Women Are Facing More of Heart Disease

Once thought to be at risk only after menopause, young women are increasingly having heart attacks and other cardiovascular events. Increasingly, studies now indicate that heart disease is increasing among young women between the ages of 18 to 55, a trend that has puzzled experts and rendered emergency rooms unprepared to recognize early warning signs among this group.

These women aren't only falling ill to the disease—they're also more prone to be sicker and to fare worse than age-matched men. They face this with further delayed diagnoses, with research indicating that women wait an average of more than two days before describing heart attack symptoms, compared with 15 hours for men.

Some of the challenge is the way heart attacks manifest in women. Men usually see the hallmark symptom of crushing chest pain, but women tend to present with more insidious, unusual symptoms, such as:

• Shortness of breath
• Jaw, back, or neck pain
• Nausea or vomiting
• Indigestion
• A feeling of dread
• Unusual fatigue or palpitations

These symptoms are commonly misinterpreted—by both physicians and patients—into stress, anxiety, or gastrointestinal distress, resulting in delays in treatment. Indeed, women are less likely to be immediately provided an electrocardiogram (EKG) in the ER and frequently are released from the ER without proper diagnostics or treatment.

Why Women Are Misdiagnosed?

Apart from symptoms, the body physiology of a woman's heart is not the same as a man's, making things even more complicated. Women have smaller vessels, are more prone to microvascular disease, and have special types of heart attacks like spontaneous coronary artery dissection (SCAD) and myocardial infarction with nonobstructive coronary arteries (MINOCA). These are the kinds that don't register on standard tests, so women's heart attacks might be completely overlooked.

More disturbing is the inherent gender bias in healthcare. Studies indicate women and minorities spend more time in the ER waiting for treatment, are less likely to be hospitalized, and do not get prescribed life-saving medications following a heart attack. The AHA says 26% of women die within one year of experiencing their first heart attack, as opposed to 19% of men.

Pioneering cardiologists are dubbing it a global health crisis. A groundbreaking consensus statement by 33 specialists from the British Cardiovascular Society has provided a vision plan for closing these disparities. The statement is urging:

• Champions and specialist centers for women's heart health
• Equal diagnostics and treatments
• More women in clinical trials
• Care models that are culturally and gender-sensitive

It also draws attention to the fact that more than 3.6 million women in the UK alone suffer from ischemic heart disease, with most getting delayed or suboptimal treatment. This is replicated all over the world—from the US to South Asia—due to old-fashioned medical beliefs, societal prejudices, and ignorance.

What Women Can Do Right Now?

For far too long, women's voices—particularly when they are reporting pain or discomfort—have been ignored or trivialized. But your body remembers when something's amiss, and listening to your heart may save your life.

Here's what you can do:

Learn your risk factors—blood pressure, cholesterol, diabetes, and family history.

Speak up for yourself—question your doctor, ask for proper tests, and don't be afraid to seek a second opinion.

Pay attention to the signs—even if they don't fit the norm.

Live a heart-healthy life—eat healthfully, stay active, cope with stress, and have regular check-ups.

Women such as Stewart, a heart attack survivor and advocate for the AHA's Go Red for Women initiative, remind us that awareness alone is not sufficient. Education, action, and advocacy are needed to turn back the deadly tide of overlooked and undiagnosed heart disease in women.

Heart disease does not discriminate, yet the medical system still does. From delay in ER treatment to exclusion from clinical trials, women are perpetually an afterthought in the world of cardiovascular medicine. That has to end. Whether you are a 20-year-old woman, a mother managing stress, or a retired grandmother, your heart matters. And so does it deserve equal attention, equal care, and a more louder voice.

When Joe Fornasero, a 34-year-old gym buff from Brighton, Michigan, visited the hospital in 2022, he felt he was as healthy as he could possibly be. For over two decades of eating clean and working out consistently, Joe had every reason to think that his healthy habits would keep him safe from chronic disease. But cancer doesn't care about the rules or so it seemed.

Only weeks into his wedding, Joe got a diagnosis so unusual that even veteran oncologists had hardly ever seen a case. He was diagnosed with Desmoplastic Small Round Cell Tumor (DSRCT)—a virulent cancer with fewer than 200 reported cases around the world since it was first discovered in 1989.

Joe's case started out as what appeared to be a routine post-surgical pain. He had just had a hernia repair and during the operation, a benign growth was taken out. Doctors told him the lingering pain and nerve problems were normal.

But the pain in his belly only grew worse. He had chronic stabbing pain in the lower left quadrant and a profound weariness he initially attributed to pandemic stress and career burnout. It wasn't until a physician-friend friend leaned on him to get to the bottom of it that Joe went to the ER. A single CT scan later, his world was turned upside down.

"I went in thinking I was the healthiest man I knew," Joe recalls. "And I came out with a potential diagnosis of cancer."

Misdiagnosis and Medical Whiplash

The initial pathology indicated small cell carcinoma—commonly found with lung cancer. With no time to lose, Joe checked himself into a hospital and underwent chemotherapy. However, something felt amiss.

He was determined to get answers, so he went to MD Anderson Cancer Center in Houston. There, physicians explained the tumors weren't in his lungs. His actual diagnosis came at the eleventh hour in a meeting with a clinical trials specialist. The actual culprit: Desmoplastic Small Round Cell Tumor—a rare and intricate cancer for which no trials were available at the time.

At home, his oncologist admitted to only having studied DSRCT in textbooks. Joe was on his own, dealing with a rare disease that few physicians had experience treating.

Upon finishing six rounds of chemotherapy at Houston, Joe learned his best hope for surgery had disappeared—his MD Anderson doctors had retired. A new hope appeared when he met Dr. LaQuellia at Memorial Sloan Kettering, a top pediatric abdominal surgeon.

The process of removing the tumors was divided into two 10-hour marathons of surgery. The first addressed the upper chest and abdomen—cutting out tumors, lymph nodes, the spleen, part of the diaphragm, and more. Miraculously, Joe was walking 24 hours after surgery.

But the respite was brief. Two cycles of intense chemo followed, along with vicious side effects—nausea, weakness, and mental exhaustion. Then there was the second extensive surgery, where tumors that were still present in his pelvis were removed. This time, Joe heard the words he had struggled so desperately for: remission.

Remission wasn't rest. Joe was aware that the recurrence rate in DSRCT was alarmingly high. He insisted on two more rounds of chemotherapy—despite their debilitating impact—and tolerated whole abdominal radiation that induced extreme gastrointestinal upset and exhaustion.

Maintenance chemo provided some stability, until breathlessness and racing hearts brought another scare. A PET scan showed him to have a one-inch blood clot in his heart. Blood thinners didn't work. Finally, he was diagnosed with early-stage congestive heart failure—a cruel twist in an already agonizing journey.

But Joe never lost hope. A repeat PET scan revealed no evidence of disease (NED). Life appeared to level out for a period. But by mid-2024, a new cause for worry arose. Swollen lymph nodes in his neck caused renewed alarm. Another scan was prescribed, hope and worry by then constant attendants.

Joe's odyssey highlights an essential reality: cancer is indiscriminate. Clean food, running, and strength training cannot entirely protect us from the medical twists of fate that life has in store. His fortitude, tenacity, and self-advocacy embody the resilience of the human condition—and highlight the glaring necessity for more awareness and support for rare cancer patients.

"I figured I was doing everything correctly," Joe says. "But cancer does not care."

His story is more than a personal battle—it’s a call to the healthcare community to invest in orphan disease research, build better diagnostic pathways, and ensure that no patient ever has to hear, “I’ve only read about this in a textbook.”

Microplastics are the latest health threat. People across the world have been left worried after recent research found that the accumulation of microplastics in the human brain is equivalent to almost a spoonful. Moreover, there is empirical evidence that shows that these tiny plastic particles can breach the blood-brain barrier that protects the brain from harmful substances.

Measuring how much plastic is in the body is tricky, so there's a lot of uncertainty in that estimate. But the fact of the matter is that scientists have seen these really small, concerning particles in the body. The question is, how harmful are they, really?

What Are Microplastics?

What we know is that plastics are all around us. They're in our furniture, our food supply, our clothes, and cosmetics, and they don't really biodegrade. They just get smaller and smaller in the environment. Microplastics are what result from that. These particles are really tiny, less than five millimeters in size. Because they're so small, they can get everywhere—into our soil, air, into the food chain and into our bodies.

How Are Microplastics Getting Inside Our Bodies?

Researchers at the University of New Mexico found that the primary way these microplastics are getting into our bodies is through ingestion. One notable finding from the lab's research was that the concentration of microplastics in our brains is increasing over time. They showed that from 2016 to 2024, the concentration of microplastics in human brains increased by almost 50%. This increase coincides with the rise of plastic in our world over time. According to some estimates, plastic production doubles every 10 to 15 years.

Do People With Dementia Have Higher Concentration Of Microplastics In Thier Brain?

One particularly concerning finding was that the brains of people with dementia had even more microplastics in them. This could be because the brains of people with dementia are less able to clear out toxins and have a more porous blood-brain barrier. Scientists are trying to figure out causation. Researchers are also investigating the link between microplastics and other health issues like fertility issues, multiple sclerosis, and heart disease.

It will still take years before scientists can actually discover how harmful are microplastics are for our brains. Here are certain things you can do to prevent the threat:

• One is not drinking from plastic water bottles, especially when they've been out in the sun.
• Another is not heating food in plastic containers.
• A third is eating lower on the food chain, so you're not consuming fish and animals that have taken in a lot of microplastics.

A lot about plastic production is not in our control. Ultimately, reducing the overall plastic in the world, has to be done at the policy level. However, doing this reporting has really made me aware that if we don't stop our plastic use and waste, it's likely that they will keep accumulating in our bodies.